Stockreport

Oncobiologics Changes Name to Outlook Therapeutics; Announces Next Steps in Executing ONS-5010 Clinical and Regulatory Strategy

ONCOBIOLOGICS  (ONS) 
US:NASDAQ Investor Relations: ir.oncobiologics.com
PDF Company changes name to Outlook Therapeutics, Inc.; ticker symbol to “OTLK”Jeff Evanson joins team as Chief Commercial OfficerTerry Dagnon joins team as Chief Operating [Read more]